Diabetes
Company collaborates with JDRF to develop clinically useful hES cells
Published in Blood Weekly, October 14th, 2004
The research will be funded through its new JDRF - Industry Discovery and Development Partnership Program that will assist ESI's development of newly derived nonxenograft human embryonic stem (hES) cells, for ultimate use in the production of hES cell-derived islets for the treatment of diabetes.
As a result of past research funded by the JDRF, it has been determined that the transplantation of insulin-producing islet cells currently offers the best hope for a cure for people with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2004-10-14)
More Articles from Blood Weekly
- Cord Blood Research
NF-kappaB activity differentially activated in cord blood - Hemodialysis
Disorders of mineral metabolism are associated with mortality in renal patients - Kidney Transplantation
Data presented on prevention of rejection after kidney transplantation - Lactobacillus
Components of L. helveticus fermented milk increase osteoblastic bone formation - Transfusion Medicine
Knowledge about infectious disease status guides our bioidentity - Anticoagulant Prophylaxis
Article reviews the epidemiology of venous thromboembolism - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
